A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
第一作者:
Reid W,Merryman
第一单位:
Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, USA. Reid_merryman@dfci.harvard.edu.
作者:
医学主题词
人类(Humans);淋巴瘤, 滤泡性(Lymphoma, Follicular);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);肿瘤复发, 局部(Neoplasm Recurrence, Local);抗肿瘤药(Antineoplastic Agents);抗体, 单克隆(Antibodies, Monoclonal);免疫疗法(Immunotherapy);肿瘤微环境(Tumor Microenvironment)
DOI
10.1007/s00277-023-05475-0
PMID
37851072
发布时间
2024-01-06
- 浏览2
Annals of hematology
185-198页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



